I have this question - could a Contract Manufacturer "release" product on behalf of client to the market? We have a Contract Manufacturer in China who compile the Device History Record (DHR) and conclude the particular lot of that product complies with the requirements. Then the product is shipped into US where our Quality will review the CoA, labels and review the DHR and then formally "release" the product to the market.
I know it is not allowed per 21 CFR 21/211 requirements and explicitly mentioned in Guidance Document on Quality Agreement, https://www.fda.gov/media/86193/download , is that allowed for medical devices? Do anyone have a similar experience?
I know it is not allowed per 21 CFR 21/211 requirements and explicitly mentioned in Guidance Document on Quality Agreement, https://www.fda.gov/media/86193/download , is that allowed for medical devices? Do anyone have a similar experience?